With Stephen Miller as Chief of Staff, Kennedy’s MAHA Agenda Is Reinvigorated + More

By The Defender Staff

in other news . . .

◼︎ GOVERNMENT

With Stephen Miller as Chief of Staff, Kennedy’s MAHA Agenda Is Reinvigorated

STAT News reported:

Even as Republicans pick up the pieces following devastating midterm election losses, spirits are high at the Department of Health and Human Services, where recent changes in the administration — namely the appointment of Stephen Miller as White House chief of staff — have put wind under the wings of health secretary Robert F. Kennedy Jr.

“The Senate has no leverage over me anymore,” Kennedy told a crowd of Make America Healthy Again supporters at an event called “A Toast to a Healthier America,” held less than a week after Republicans lost control of the House and Senate to Democrats.

Stefanie Spear, Kennedy’s ever-present principal deputy chief of staff, has been telling staff that Miller’s effusive support of MAHA means it’s go time, according to one person familiar with the department, who spoke with STAT on the condition of anonymity because they are not authorized to speak publicly.

Cassidy Calls for Trump to Replace Kennedy at HHS

Newsmax reported:

Sen. Bill Cassidy, R-La., called Sunday for President Donald Trump to replace Health and Human Services Secretary Robert F. Kennedy Jr., saying his handling of measles, rising healthcare costs, and ultraprocessed foods amounts to a series of failures.

“If I were president, I would choose someone else because there needs to be accountability for higher healthcare costs, more measles deaths, losing elimination status, and no progress on processed foods,” Cassidy told CBS’ “Face the Nation.”

Cassidy, a physician who chairs the Senate Health, Education, Labor and Pensions Committee, said Kennedy’s record could damage Trump’s legacy unless the president changes course.

Senate Health Chair Unsure if Trump’s FDA Pick Has Support to Pass Committee’s Vote

The Washington Post reported:

The top Republican on the Senate health committee said Sunday he was not sure whether Heidi Overton, President Donald Trump’s pick to lead the Food and Drug Administration, had the necessary support to survive a key vote on her nomination scheduled for this week.

Sen. Bill Cassidy (R-Louisiana), chair of the Senate Committee on Health, Education, Labor and Pensions, said during an interview on CBS’s “Face the Nation” that he still had questions about Overton’s suitability for the role and her support for an executive order President Trump signed in August reducing the number of recommended child vaccines. Cassidy’s committee is expected to vote Wednesday on whether to advance Overton’s nomination for consideration by the full Senate.

“I still have questions, so I cannot tell you the outcome of that vote right now,” Cassidy, a physician, said Sunday. He added that the choice, for him, was whether to back a nominee about whom he holds reservations or whether to vote “no” and leave the position unfilled as Democrats take control of Congress next year.

NIAID Acting Head John Powers III Appointed as the Permanent Director

STAT News reported:

The acting director of the National Institute of Allergy and Infectious Diseases, John Powers III, will become the permanent director, the agency announced Monday.

NIAID has been without a permanent director since March 2025, when the Trump administration ousted Jeanne Marrazzo. Powers has been serving in an acting capacity since June. A physician-scientist, Powers has worked with NIAID since 1999 in several roles focused on clinical research.

The second Trump administration has brought a renewed spotlight to the infectious disease institute, in large part because of the president’s ire for former director Anthony Fauci, and because of unsubstantiated accusations that research funded by an institute in China played a role in creating the SARS-CoV-2 virus.

It has also seen tumult in its leadership. After Marrazzo was ousted, Jeffery Taubenberger was appointed acting director. He unexpectedly stepped down, and several other leaders at NIAID were reassigned to other institutes or asked to resign.

◼︎ BIG CHEMICAL

Carbon Emissions of Biggest U.S. Data Centers Already Rival Entire Countries, Study Reveals

The New York Times reported:

The largest data centers in the United States are responsible for an estimated 25.7 million metric tons of carbon dioxide emissions annually — almost as much as entire countries like Bolivia or Denmark — according to new research.

The study, published Monday in the journal Nature Sustainability, delivers the first peer-reviewed estimates of carbon dioxide emissions from the country’s biggest data centers since the start of the artificial intelligence boom. Its authors, a team led by researchers from Harvard University, examined the electricity consumption and carbon emissions of 403 data centers from May 2024 to April 2025.

All told, those data centers used almost 2 percent of U.S. electricity, more than New York City and Los Angeles combined, and represented about 0.5 percent of U.S. carbon dioxide emissions. Carbon dioxide is the primary greenhouse gas driving global warming.

The Link Between Microplastics and One of the Deadliest Cancers, and What to Do

The Washington Post reported:

For the past couple of decades, doctors and researchers have monitored rising colon cancer rates among young people with concern. In the United States, colorectal cancer rates increased by 3 percent every year among adults ages 20 to 49 between 2013 and 2022. Researchers have suspected highly processed foods, toxins in the gut and sedentary lifestyles. Now there is a new suspect: microplastics.

A study released last month from researchers at Central South University in China found that long-term exposure to polystyrene nanoplastics — the plastic that is used in Styrofoam cups and take-out containers — promoted tumor growth in mice that were genetically modified to be predisposed to colon cancer for research purposes.

The nanoplastics, researchers found, built up in the colon, disrupting the cells lining the gut and damaging the balance of gut bacteria. The mice exposed to nanoplastics had more tumors and more severe tumors than those that were not exposed.

Groups Petition EPA To Lower Drinking Water Limit For Carcinogenic Nitrates

Food & Water Watch reported:

Today, a coalition of public health and environmental organizations filed a petition calling on the Environmental Protection Agency (EPA) to lower the federal safety threshold for nitrates in drinking water to 1mg/L. The current threshold of 10mg/L was first adopted in 1975 and EPA has never updated it since.

Public health research in the intervening 51 years clearly shows that nitrate-contaminated drinking water at levels far below the current standard is associated with increased risk of cancer, birth defects, and more. Unchecked factory farm and chemical fertilizer pollution are the nation’s primary sources of waterway nitrate contamination.

Today roughly 1 in 3 Americans — nearly 120 million people — are exposed to dangerous nitrate levels in their tap water. The petition filing comes as Trump’s EPA has apparently abandoned a re-assessment of nitrate’s toxicity and eliminated the offices responsible for conducting such assessments, scuttling years of work done under prior administrations.

Annual Water‑Quality Reports Don’t Tell the Full Story of What You’re Drinking

The Conversation reported:

Water is vital to life, which is part of why we study what’s in it. Drinking water isn’t just H₂O – though there are over 15 septillion molecules of it in a standard glass. It also contains natural minerals, dissolved organic and biological matter, and substances that enter from agriculture, industry, consumer products and water treatment.

Most of these substances are harmless at the concentrations typically found in water. Some are beneficial, and even essential, such as sodium, fluoride and calcium ions, which build strong bones and teeth. Additionally, these ions balance electrolytes that regulate bodily function.

In fact, drinking large quantities of completely demineralized or distilled water can disrupt the body’s electrolyte balance. This water would dilute the natural sodium levels in blood, potentially causing hyponatremia, a condition with symptoms such as nausea, headache, confusion and seizures.

Most people encounter water-quality science through an annual report from their local water company. It’s usually a couple of pages long with chemical names and numbers in a table. It lists various compounds that may exist in the water, summarizes what has been found in tests of the water source, and explains whether the water meets government-set standards that promote and protect public health and safety.

◼︎ BIG PHARMA

WHO Sounds the Alarm on Antimicrobial Resistance Threat

MedicalXPress reported:

The spread of antimicrobial resistance (AMR) is threatening modern medicine despite progress in combating drug-resistant bacteria, senior World Health Organization officials said Monday.

WHO officials said countries had expanded efforts to tackle AMR, but warned that progress in prevention, diagnosis and the appropriate use of antibiotics remained too slow to meet global targets.

Bacteria have long evolved resistance to medicines designed to kill them.

The widespread use of antibiotics in human health, animal husbandry and food production has accelerated the problem, making AMR one of the leading causes of infectious disease deaths worldwide.

Novo Says Wegovy Injection Lowers BMI and Obesity Rates in Children in Trial

CNBC reported:

Novo on Monday released full results from a late-stage trial showing its blockbuster Wegovy injection helped children ages 6 to under 12 with obesity shed weight, significantly lowering their body mass index.

Wegovy reduced BMI by an estimated 19.7 percentage points on average compared with a placebo at 68 weeks, with BMI falling 17.4% among children receiving the drug and rising 2.2% among those receiving a placebo. Those results assumed patients stayed on treatment during the trial.

When evaluating all children in the study, including those who discontinued treatment, Wegovy lowered BMI by an estimated average of 16.2 percentage points more than the placebo at 68 weeks. All 167 kids in the study received lifestyle modifications throughout the trial, including a ​reduced-calorie diet and increased physical activity.

AstraZeneca Bet $2 Billion on Summit’s Cancer Drug. The FDA Just Said Not Yet.

Barron’s reported:

Summit Therapeutics investors were hoping a landmark regulatory approval would validate an entire class of next-generation cancer drugs. That didn’t go to plan — at least, not yet. Over the weekend, Summit disclosed that the Food and Drug Administration had declined to approve its novel lung-cancer treatment, ivonescimab, in combination with chemotherapy. In a letter to the company, regulators indicated that the drug couldn’t be approved in its current form, given the lack of evidence that it actually helps patients live longer.

The FDA specifically pointed to the absence of a statistically significant improvement in overall survival—the length of time patients remain alive after starting treatment. Overall survival is considered the “gold standard” endpoint in clinical trials because death is a clear, unambiguous event that isn’t subject to bias.

Instead, Summit’s trials hinged on progression-free survival, which measures how long a patient lives with the disease without it getting worse during and after treatment. That benefit alone wasn’t enough to support approval, regulators said.

The post With Stephen Miller as Chief of Staff, Kennedy’s MAHA Agenda Is Reinvigorated + More appeared first on Children’s Health Defense.

 

IPAK-EDU is grateful to The Defender as this piece was originally published there and is included in this news feed with mutual agreement. Read More

Subscribe to SciPublHealth


Science-based knowledge, not narrative-dictated knowledge, is the goal of WSES, and we will work to make sure that only objective knowledge is used in the formation of medical standards of care and public health policies.

Comments


Join the conversation! We welcome your thoughts, feedback, and questions. Share your comments below.

Leave a Reply